Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes

Show full item record




Kaustio , M , Haapaniemi , E , Göös , H , Hautala , T , Park , G , Syrjänen , J , Einarsdottir , E , Sahu , B , Kilpinen , S , Rounioja , S , Fogarty , C L , Glumoff , V , Kulmala , P , Katayama , S , Tamene , F , Trotta , L , Morgunova , E , Krjutskov , K , Nurmi , K , Eklund , K , Lagerstedt , A , Helminen , M , Martelius , T , Mustjoki , S , Taipale , J , Saarela , J , Kere , J , Varjosalo , M & Seppanen , M 2017 , ' Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes ' , Journal of Allergy and Clinical Immunology , vol. 140 , no. 3 , pp. 782-796 . https://doi.org/10.1016/j.jaci.2016.10.054

Title: Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes
Author: Kaustio, Meri; Haapaniemi, Emma; Göös, Helka; Hautala, Timo; Park, Giljun; Syrjänen, Jaana; Einarsdottir, Elisabet; Sahu, Biswajyoti; Kilpinen, Sanna; Rounioja, Samuli; Fogarty, Christopher L.; Glumoff, Virpi; Kulmala, Petri; Katayama, Shintaro; Tamene, Fitsum; Trotta, Luca; Morgunova, Ekaterina; Krjutskov, Kaarel; Nurmi, Katariina; Eklund, Kari; Lagerstedt, Anssi; Helminen, Merja; Martelius, Timi; Mustjoki, Satu; Taipale, Jussi; Saarela, Janna; Kere, Juha; Varjosalo, Markku; Seppanen, Mikko
Contributor organization: University of Helsinki
Institute for Molecular Medicine Finland
Institute of Biotechnology
Department of Clinical Chemistry and Hematology
Research Programs Unit
Päivi Marjaana Saavalainen / Principal Investigator
Research Programme of Molecular Medicine
Jussi Taipale / Principal Investigator
Genome-Scale Biology (GSB) Research Program
Nefrologian yksikkö
Department of Medicine
Diabetes and Obesity Research Program
Reumatologian yksikkö
Infektiosairauksien yksikkö
Department of Oncology
Janna Saarela / Principal Investigator
Juha Kere / Principal Investigator
Research Programme for Molecular Neurology
Molecular Systems Biology
Children's Hospital
HUS Children and Adolescents
HUS Comprehensive Cancer Center
HUS Inflammation Center
HUS Internal Medicine and Rehabilitation
HUS Abdominal Center
Date: 2017-09
Language: eng
Number of pages: 15
Belongs to series: Journal of Allergy and Clinical Immunology
ISSN: 0091-6749
DOI: https://doi.org/10.1016/j.jaci.2016.10.054
URI: http://hdl.handle.net/10138/297945
Abstract: Background: The nuclear factor kappa light-chain enhancer of activated B cells (NF-kappa B) signaling pathway is a key regulator of immune responses. Accordingly, mutations in several NF-kappa B pathway genes cause immunodeficiency. Objective: We sought to identify the cause of disease in 3 unrelated Finnish kindreds with variable symptoms of immunodeficiency and autoinflammation. Methods: We applied genetic linkage analysis and next-generation sequencing and functional analyses of NFKB1 and its mutated alleles. Results: In all affected subjects we detected novel heterozygous variants in NFKB1, encoding for p50/p105. Symptoms in variant carriers differed depending on the mutation. Patients harboring a p.I553M variant presented with antibody deficiency, infection susceptibility, and multiorgan autoimmunity. Patients with a p.H67R substitution had antibody deficiency and experienced autoinflammatory episodes, including aphthae, gastrointestinal disease, febrile attacks, and small-vessel vasculitis characteristic of Behc, et disease. Patients with a p.R157X stop-gain experienced hyperinflammatory responses to surgery and showed enhanced inflammasome activation. In functional analyses the p.R157X variant caused proteasome-dependent degradation of both the truncated and wild-type proteins, leading to a dramatic loss of p50/p105. The p.H67R variant reduced nuclear entry of p50 and showed decreased transcriptional activity in luciferase reporter assays. The p.I553M mutation in turn showed no change in p50 function but exhibited reduced p105 phosphorylation and stability. Affinity purification mass spectrometry also demonstrated that both missense variants led to altered protein-protein interactions. Conclusion: Our findings broaden the scope of phenotypes caused by mutations in NFKB1 and suggest that a subset of autoinflammatory diseases, such as Behcet disease, can be caused by rare monogenic variants in genes of the NF-kappa B pathway.
Subject: Nuclear factor k light-chain enhancer of activated B cells
Behcet disease
B cell
3111 Biomedicine
3121 General medicine, internal medicine and other clinical medicine
Peer reviewed: Yes
Usage restriction: openAccess
Self-archived version: publishedVersion

Files in this item

Total number of downloads: Loading...

Files Size Format View
1_s2.0_S0091674917300532_main.pdf 3.959Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record